GlassScriptPhysician profile
Forrest R Cote
NPI 1396942173
$1,573.41
in general payments reported to CMS, 2019-2025
16 companies · $180 in 2025
The $180 reported for 2025 was more than what 79% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $16.87 · 2021: $462 · 2022: $155 · 2023: $307 · 2024: $215 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $701.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $573.26 | 2021-2024 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $155.75 | 2019-2024 | Hemosphere |
| Becton, Dickinson and Company | $155.33 | 2025 | Hemosphere |
| Abiomed | $143.12 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $106.52 | 2019-2021 | |
| Abbott Laboratories | $97.72 | 2021-2022 | |
| Acacia Pharma INC | $91.00 | 2021 | |
| Celgene Corporation | $76.91 | 2019 | |
| Atricure, INC. | $38.15 | 2023 | |
| Bard Peripheral Vascular, INC. | $27.73 | 2023 | Rotarexs 6 F X 135 Cm |
| Ambu INC. | $24.39 | 2025 | |
| Livanova USA, INC. | $18.61 | 2022 | |
| Vyaire Medical, INC. | $17.67 | 2023 | |
| Masimo Corporation | $17.09 | 2021 | |
| Getinge USA Sales, LLC | $16.87 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Cote listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.